ANMAT Halts Biotenk S.A. – Argentina Health Alert
Argentina’s Pharmaceutical Quality Crisis: A Harbinger of Global Supply Chain Vulnerabilities Over 15% of pharmaceutical manufacturers in Argentina have faced recent sanctions, including production halts and license revocations, due to critical irregularities. This isn’t simply a localized issue; it’s a stark warning about the increasing fragility of global pharmaceutical supply chains and the potential for … Read more